HappeningToo topic
Emtricitabine and Tenofovir Disoproxil Fumarate reports
Browse community reports connected to Emtricitabine and Tenofovir Disoproxil Fumarate. These reports can show that other people are describing similar experiences, but they do not prove that Emtricitabine and Tenofovir Disoproxil Fumarate caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
19 problems
Abdominal Pain while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and abdominal pain appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and anxiety appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and back pain appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and diarrhea appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and dizziness appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and fatigue appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and headache appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and insomnia appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and itching appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and malaise appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and myalgia appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and nausea appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and pain appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and rash appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and shortness of breath appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and vomiting appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and weakness appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and weight decreased appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Emtricitabine and Tenofovir Disoproxil Fumarate
FDA FAERS contains adverse-event reports in which Emtricitabine and Tenofovir Disoproxil Fumarate and weight increased appear together. This does not establish that Emtricitabine and Tenofovir Disoproxil Fumarate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →